Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Leukemia. 2013 Sep 5;28(2):398–403. doi: 10.1038/leu.2013.258

Table 3.

Relationship between Non-overlapping primary molecular cytogenetic abnormalities and myeloma defining event at diagnosis in patients with Trisomies.

FISH Abnormality Overall Bone Disease variant
No. of patients (%)		 Renal Failure variant
No. of patients (%)		 Anemia variant
No. of patients (%)		 Mixed variant
No. of patients (%)
All trisomies 275 96 (34.9%) 11 (4.0%) 45 (16.4%) 123 (44.7%)
Trisomy alone without other abnormality 236 84 (35.6%) 9 (3.8%) 34 (14.4%) 106 (44.9%)
No trisomies 209 72 (34.4%) 26 (12.4%) 26 (12.4%) 85 (40.7%)
*

Number and proportion represents the breakdown of patients with each cytogenetic subtype according to MDE